NaMo Naresh not yet arrested; we will catch him soon: Mangaluru police chief

Lucknow, Feb 24: The Uttar Pradesh Sunni Central Waqf Board on Monday accepted the five acres of land provided for construction of the mosque in Ayodhya.

The Board also decided to form a trust to oversee the construction of the mosque.

The decision was taken in a meeting chaired by the Board's Chairman Zufar Faruqui.

Apart from this, the trust will also construct a charitable hospital, public library and a centre showcasing the heritage of Indo-Islamic civilisation which will also serve as a research and study centre for the same, according to a press release by the board.

The appointment of members to the trust will be announced following its creation, the release added.

The Supreme Court had on November 9 last year directed the Central government to hand over the disputed site at Ayodhya for the construction of a temple and set up a trust for the same.

The apex court had further directed the government to allocate an alternative five acres of land at a prominent location in Ayodhya for the construction of a mosque to the Sunni Waqf Board.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Udupi, Jan 1: A 53-year-old Journalist of a Mangalore-based media house was found dead at his flat in Manipal on Tuesday.

The deceased has been identified as Rohit Raj (53), a resident of Pandeshwar Mangaluru.

According to the Manipal police, on December 31, Rohit Raj had attended a New Year party celebration at Kadiyali, Udupi along with his wife.